Search
Labcorp Holdings Inc
LHAdd to Watchlist
255.820USD
-3.690-1.42%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
20.98BMarket Cap
22.51P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Labcorp Holdings Inc is 8.20, ranking 25 out of 76 in the Healthcare Providers & Services industry. The average price target is 304.00, with a high of 342.00 and a low of 260.00.
Analyst Rating
Based on
20
analysts
Buy
Current Rating
307.347
Target Price
+18.41%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Labcorp Holdings Inc
LH
20
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Tenet Healthcare Corp
THC
23
Natera Inc
NTRA
21
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Labcorp Holdings Inc's expected revenue for the next quarter?
Labcorp Holdings Inc's expected revenue is 3.71B.
What is Labcorp Holdings Inc's price target?
Analysts forecast that Labcorp Holdings Inc's price target is USD 304.00, with the highest forecast at USD 342.00 and the lowest forecast at USD 260.00.
How have Labcorp Holdings IncLH's recent earnings per share performed?
The market expectation was USD 3.38, while Labcorp Holdings IncLH's earnings per share (EPS) for the previous quarter was USD 3.14. EPS for the next quarter is expected at USD 4.78.
What is the analyst rating for Labcorp Holdings Inc?
Based on the ratings of Labcorp Holdings Inc's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
